Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has published a newspaper notice informing shareholders about a special window for re-lodging transfer requests of physical securities. The window, open from February 5, 2026 to February 4, 2027, allows holders of physical shares sold or purchased before April 1, 2019, or those whose earlier transfer requests were rejected or returned due to document deficiencies, to re-submit their requests. The company's RTA is KFin Technologies Limited. Transferred securities will be credited only in demat form and will be under a mandatory one-year lock-in period during which they cannot be transferred, lien-marked, or pledged.
This is a routine compliance notice under SEBI directives to phase out physical share certificates. It does not directly impact financials or stock price but benefits shareholders holding old physical shares by giving them a one-year window to convert holdings to demat form.